Please login to the form below
Vanguards
This page shows the latest Vanguards news and features for those working in and with pharma, biotech and healthcare.
Bluebird gets European recommendation for gene therapy Zynteglo
The recommendation is a huge milestone for the Cambridge, Mass-based biotech, and confirms its place among the vanguard of new gene therapy companies.
Latest news
-
Biosimilar Herceptin helps Roche gain new Perjeta recommendation
NICE decision puts NHS in vanguard for new use. NICE has a history of rowing with Roche over its breast cancer drugs, but peace has broken out in recent times - and
-
Plasticell and London’s gene therapy pioneers to tackle manufacturing conundrum
London’s top research universities are in the vanguard, with two cell and gene biotech companies, Autolus and Orchard Therapeutics, both spun out of work done by UCL.
-
Innovating patient care
His institution is also part of a vanguard project with London hospitals the Royal Marsden and UCLH. ... Tying something to the badge of Cancer Vanguard does open doors,” he adds.
-
A Schengen area of healthcare
borders. The creation of EHRO would overcome past challenges and put the EU at the vanguard of the new digital century of health.
-
Upwardly mobile: Pharma opportunities in mHealth
The delivery of healthcare services is changing and mobile technology is in the vanguard.
More from news
Approximately 0 fully matching, plus 11 partially matching documents found.
Latest Intelligence
-
The first, my last, my everything
One of the most prominent advocates is UCB, whose pioneering reorganisation around ‘patient value creation’ put the company at the vanguard of the movement.
-
Bluebird Bio: on the cusp of a gene therapy revolution
Even though they didn’t end up being commercial successes, these approvals have put the EMA in the vanguard of gene therapy – and demonstrated to companies such as Spark and Bluebird
-
Effective strategic planning
stakeholders such as vanguards and CCGs as well as patients, allows us “to gather insights on trends and gaps or inefficiencies in patient care in a variety of priority and
-
Keeping it real
What’s next for VR/AR? At the vanguard of visual technology research is mixed reality (MR): a fully integrated combination of augmented and virtual reality that adds content to your
-
Tracking comms trends: Europe in the global vanguard on value
In some companies, European teams are now undergoing a transformation in the eyes of their global peers - from comparative underperformer to vanguard and teacher.
More from intelligence
Approximately 0 fully matching, plus 8 partially matching documents found.
Latest appointments
-
imc, ROAD, Executive Insight and Life Healthcare adds to teams
It’s exciting to be in the vanguard.”. Working alongside Ravenhill is Shan Peng, who has joined the group as its compliance director.
-
JMC Partners strengthens senior team
John Murray, managing director of JMC, said: “Andrew's arrival consolidates our position in the vanguard of healthcare policy. In particular, his knowledge of primary care will prove invaluable as the
-
Ironwood appoints Edward Owens to board
Owens served at Wellington from 1974 to his retirement in 2012, spending 18 years as portfolio manager for the Vanguard Health Care Fund. ... During his tenure, the Vanguard Health Care Fund was the best performing mutual fund among all mutual funds.
More from appointments
Approximately 0 fully matching, plus 3 partially matching documents found.
Latest from PMHub
-
Early diagnosis underpins NHS cancer strategy
The 10 pilot RDCs are mostly clustered around the cancer vanguard areas of London and Manchester, with five in London, two in Manchester and one each in Leeds, Oxford, and Airedale,
-
GPs will play a pivotal role in integrated care
Areas that worked as Vanguards, or have already morphed into ICSs, will be first off the blocks in putting the new GP contract into practice.
-
From Cowgirl to Medical Writer - How did that happen?
To work with experts at the vanguard of healthcare research is a privilege, and to work with clients to create magical programmes is hugely stimulating.
-
Sir Bruce Keogh is appointed chair of judges for HSJ Awards
As the first medical director of, initially, the Department of Health and then NHS England he was in the vanguard of national initiatives to drive up healthcare quality during a period
-
How can pharma engage with key decision-makers in new, collaborative NHS care models?
Group consensus is key for STPs . STPs were introduced to build on the work of the Vanguards and implement a place-based care system that incorporates both health and social care. ... Key decision-makers in ICSs will grow out of STPs, Vanguards and
More from PMHub
Approximately 3 fully matching, plus 8 partially matching documents found.
Featured jobs
-
Vice President
-
Competitive Salary Offered
- Account Director, Medical Communications & Events
-
£50 - 65, 000 according to skills and experience benefits
-
Consultant
-
competitive salary
-
Principal Medical Writer
-
£48 - 58, 000 according to skills and experience benefits
- Account Manager– Medical Communications
-
(Negotiable - depending on experience)
- Senior Medical Writer, MedComms Agency
-
Salary TBC
- Director of Scientific Services, Medical Communications, Six fig...
-
Six figure salary
- Account Director or Senior Account Director
-
Salary TBC
Subscribe to our email news alerts
- Novartis links up with NHS for speedy access to cholesterol drug inclisiran
- NantKwest rockets on promising pancreatic cancer data
- FDA starts priority review of BMS Opdivo/Yervoy in first-line NSCLC
- Genital herpes vaccine candidate heads for human studies
- Bayer bulks up in women’s health again with non-hormonal contraceptive deal
- Welcome to the Communique Awards - Communiqué Awards 2018
- How do companies prepare for reimbursement?
- Lucid Group adds more magic to the mix with four new hires
- Communiqué Awards 2020 is now open for entry
- Novo Nordisk gets MACE prevention claim for Ozempic in US
- NICE leaves the ‘the NHS door’ open despite rejecting Bayer’s Vitrakvi
- FDA committee rejects Intellipharmaceutics’ opioid drug Aximris
PMHub
Market Access Transformation
Market Access Transformation (MAT), founded by industry veterans Baiju Aurora and Paul Howard, specializes in developing cutting edge technologies that...
Latest intelligence
- How do companies prepare for reimbursement?
- Valid Insight explore how to optimise your market access strategy during new product development, how to address payer concerns and prepare for reimbursement....
- Integrating electronic health records into clinical trials
- How organisations are working to realise the research potential of EHRs...
- Keeping up the fight against HIV and using the lessons to tackle other threats
- Danny Buckland interviews Gilead’s Mike Elliott...
Quick links
Infographics
